A

Amgen

Makes biotech medicines for serious illnesses

Global Safety Officer, Medical Director - Rare Disease

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • An MD or DO degree from an accredited medical school.
  • Completion of an accredited medical or surgical residency, or relevant clinical experience in an academic, hospital-based, or private practice setting.

Responsibilities

  • Serve as the accountable physician safety leader for assigned Rare Disease development programs.
  • Lead global safety strategy for clinical development programs, primarily Phase 1b and Phase 2 studies.
  • Partner with Clinical Development and Translational Medicine teams to inform dose-escalation, cohort expansion, proof-of-concept, and development decisions.
  • Provide medical safety leadership and contribute to benefit-risk evaluations throughout clinical development.
  • Review and interpret emerging safety data and communicate safety implications to development teams and governance committees.
  • Lead the Safety Analysis Team (SAT) and Global Safety Team (GST), and participate in Executive Safety Committee (ESC) discussions.
  • Review and contribute to Safety Review Committees (SRCs), Data Monitoring Committees (DMCs), and other safety governance forums.
  • Validate safety signals and lead signal detection, assessment, and risk evaluation activities.
  • Develop and maintain Core Safety Information, including Core Data Sheets and informed consent safety language.
  • Prepare and review Risk Management Plans (RMPs), risk minimization strategies, and aggregate safety reports.
  • Lead safety review and provide strategic input into protocol development, case report form (CRF) design, Statistical Analysis Plans, Clinical Study Reports, and safety monitoring plans.
  • Prepare and review safety sections of regulatory submissions, including INDs, CTAs, BLAs, NDAs, and other global submissions.
  • Serve as the safety representative on Evidence Generation Teams and other cross-functional development teams.
  • Support regulatory inspections and inspection readiness activities.
  • Travel domestically and internationally up to 10%.

Desired Qualifications

  • At least 8 years of pharmaceutical industry experience in Drug Safety, Clinical Safety, Pharmacovigilance, or Clinical Development.
  • Demonstrated experience serving as a Global Safety Officer (GSO), Clinical Safety Lead, Safety Lead Physician, or equivalent accountable safety leader.
  • Significant experience supporting Phase 1b and Phase 2 clinical development programs.
  • Experience in Early Clinical Development, including First-in-Human, dose escalation, cohort expansion, proof-of-concept, and translational medicine programs.
  • Direct experience influencing clinical development through protocol development, CRF design, safety monitoring plans, dose-escalation decisions, and benefit-risk assessments.
  • Expertise in signal detection, signal assessment, benefit-risk evaluation, risk management, and safety governance.
  • Experience supporting regulatory submissions and interactions with health authorities, including INDs, CTAs, BLAs, NDAs, MAAs, and responses to regulatory questions.
  • Experience presenting safety assessments and recommendations to governance committees, development teams, and regulatory authorities.
  • Experience supporting Rare Disease clinical development programs is strongly preferred.
  • Expertise in inflammatory, neuroinflammatory, autoimmune, complement-mediated, vasculitis, endocrine, metabolic, genetic, or other orphan disease indications is strongly preferred.
  • Experience supporting biologics, monoclonal antibodies, gene therapies, or other innovative modalities in clinical development is preferred.
  • Demonstrated leadership in cross-functional matrix organizations, with the ability to influence development strategy and drive decision-making.
  • Experience with both clinical development and post-marketing safety activities is preferred.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs